# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 2491-2500 of 2727 results.
Exemestane in Treating Patients With Complex Atypical Hyperplasia of the Endometrium/Endometrial Intraepithelial Neoplasia or Low Grade Endometrial Cancer
Status: Recruiting
Last Changed: Jun 11, 2020
First Received: Oct 03, 2017
Disease(s): Atypical Hyperplasia, Endometrial Intraepithelial Neoplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
Intervention(s): Exemestane, Laboratory Biomarker Analysis, Pharmacokinetic Study, Questionnaire Administration
Locations: University of Alabama at Birmingham Cancer Center, Birmingham, Alabama, United States
University of Minnesota/Masonic Cancer Center, Minneapolis, Minnesota, United States
University of Wisconsin Hospital and Clinics, Madison, Wisconsin, United States
Galliera Hospital, Genoa, Italy
Enzalutamide, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV or Recurrent Endometrioid Endometrial Cancer
Status: Recruiting
Last Changed: May 15, 2020
First Received: Feb 17, 2016
Disease(s): Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7, Stage IIIC Uterine Corpus Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7, Stage IVA Uterine Corpus Cancer AJCC v7, Stage IVB Uterine Corpus Cancer AJCC v7
Intervention(s): Carboplatin, Enzalutamide, Laboratory Biomarker Analysis, Paclitaxel, Pharmacological Study
Locations: M D Anderson Cancer Center, Houston, Texas, United States
The Woman's Hospital of Texas, Houston, Texas, United States
MD Anderson in Katy, Houston, Texas, United States
MD Anderson League City, Nassau Bay, Texas, United States
MD Anderson in Sugar Land, Sugar Land, Texas, United States
... and 2 other locations.
VSV-hIFNbeta-NIS With or Without Ruxolitinib Phosphate in Treating Patients With Stage IV or Recurrent Endometrial Cancer
Status: Recruiting
Last Changed: Aug 07, 2020
First Received: Apr 19, 2017
Disease(s): Metastatic Endometrial Carcinoma, Recurrent Endometrial Adenocarcinoma, Recurrent Endometrial Carcinoma, Recurrent Endometrial Clear Cell Adenocarcinoma, Recurrent Endometrial Endometrioid Adenocarcinoma, Recurrent Endometrial Mixed Cell Adenocarcinoma, Recurrent Endometrial Serous Adenocarcinoma, Recurrent Endometrial Undifferentiated Carcinoma, Recurrent Uterine Corpus Carcinosarcoma, Stage IV Uterine Corpus Cancer AJCC v7, Stage IVA Uterine Corpus Cancer AJCC v7, Stage IVB Uterine Corpus Cancer AJCC v7
Intervention(s): Biopsy, Computed Tomography, Fluorine F 18 Tetrafluoroborate, Laboratory Biomarker Analysis, Pharmacological Study, Planar Imaging, Positron Emission Tomography, Recombinant Vesicular Stomatitis Virus-expressing Human Interferon Beta and Sodium-Iodide Symporter, Ruxolitinib, Ruxolitinib Phosphate, Single Photon Emission Computed Tomography, Technetium Tc-99m Sodium Pertechnetate
Locations: Mayo Clinic in Rochester, Rochester, Minnesota, United States
Vaccine Therapy With or Without Sargramostim in Treating Patients With Advanced or Metastatic Cancer
Status: Completed
Last Changed: Jan 25, 2013
First Received: Jan 27, 2003
Disease(s): Adenocarcinoma of the Colon, Adenocarcinoma of the Gallbladder, Adenocarcinoma of the Pancreas, Adenocarcinoma of the Rectum, Adult Primary Hepatocellular Carcinoma, Advanced Adult Primary Liver Cancer, Cholangiocarcinoma of the Gallbladder, Diffuse Adenocarcinoma of the Stomach, Intestinal Adenocarcinoma of the Stomach, Male Breast Cancer, Mixed Adenocarcinoma of the Stomach, Ovarian Endometrioid Adenocarcinoma, Paget Disease of the Breast With Intraductal Carcinoma, Paget Disease of the Breast With Invasive Ductal Carcinoma, Recurrent Adult Primary Liver Cancer, Recurrent Breast Cancer, Recurrent Colon Cancer, Recurrent Gallbladder Cancer, Recurrent Gastric Cancer, Recurrent Malignant Testicular Germ Cell Tumor, Recurrent Pancreatic Cancer, Recurrent Rectal Cancer, Recurrent Salivary Gland Cancer, Salivary Gland Adenocarcinoma, Stage II Malignant Testicular Germ Cell Tumor, Stage II Pancreatic Cancer, Stage III Colon Cancer, Stage III Gastric Cancer, Stage III Malignant Testicular Germ Cell Tumor, Stage III Pancreatic Cancer, Stage III Rectal Cancer, Stage III Salivary Gland Cancer, Stage IIIA Breast Cancer, Stage IIIB Breast Cancer, Stage IV Breast Cancer, Stage IV Colon Cancer, Stage IV Gastric Cancer, Stage IV Pancreatic Cancer, Stage IV Rectal Cancer, Stage IV Salivary Gland Cancer, Thyroid Gland Medullary Carcinoma, Unresectable Gallbladder Cancer
Intervention(s): recombinant fowlpox-CEA(6D)/TRICOM vaccine, sargramostim, recombinant fowlpox GM-CSF vaccine adjuvant
Locations: Fox Chase Cancer Center, Philadelphia, Pennsylvania, United States
Cabozantinib S-Malate in Treating Patients With Recurrent or Metastatic Endometrial Cancer
Status: Active, not recruiting
Last Changed: Jul 14, 2020
First Received: Sep 05, 2013
Disease(s): Endometrial Adenosquamous Carcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Cell Adenocarcinoma, Endometrial Serous Adenocarcinoma, Metastatic Endometrioid Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage IV Uterine Corpus Cancer AJCC v7, Stage IVA Uterine Corpus Cancer AJCC v7, Stage IVB Uterine Corpus Cancer AJCC v7, Uterine Corpus Carcinosarcoma
Intervention(s): Cabozantinib S-malate, Laboratory Biomarker Analysis, Pharmacological Study
Locations: City of Hope Comprehensive Cancer Center, Duarte, California, United States
Los Angeles County-USC Medical Center, Los Angeles, California, United States
USC / Norris Comprehensive Cancer Center, Los Angeles, California, United States
City of Hope South Pasadena, South Pasadena, California, United States
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States
... and 16 other locations.
Levonorgestrel-Releasing Intrauterine System With or Without Everolimus in Treating Patients With Atypical Hyperplasia or Stage IA Grade 1 Endometrial Cancer
Status: Recruiting
Last Changed: Jul 23, 2020
First Received: Mar 24, 2015
Disease(s): Atypical Endometrial Hyperplasia, FIGO Grade 1 Endometrial Endometrioid Adenocarcinoma, FIGO Grade 2 Endometrial Endometrioid Adenocarcinoma
Intervention(s): Everolimus, Laboratory Biomarker Analysis, Levonorgestrel-Releasing Intrauterine System
Locations: Queen's Medical Center, Honolulu, Hawaii, United States
American Health Network Inc, Indianapolis, Indiana, United States
Summit Medical Group, Berkeley Heights, New Jersey, United States
Cooper Hospital University Medical Center, Camden, New Jersey, United States
OhioHealth Mansfield Hospital, Mansfield, Ohio, United States
... and 10 other locations.
PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer
Status: Active, not recruiting
Last Changed: Oct 08, 2020
First Received: Nov 29, 2012
Disease(s): Endometrial Clear Cell Adenocarcinoma, Endometrial Mixed Adenocarcinoma, Endometrial Serous Adenocarcinoma, Grade 3 Endometrial Endometrioid Adenocarcinoma, Malignant Mixed Mesodermal (Mullerian) Tumor
Intervention(s): Computed Tomography, Indocyanine Green Solution, Laboratory Biomarker Analysis, Lymph Node Mapping, Lymphadenectomy, Positron Emission Tomography
Locations: Lyndon Baines Johnson General Hospital, Houston, Texas, United States
M D Anderson Cancer Center, Houston, Texas, United States
The Woman's Hospital of Texas, Houston, Texas, United States
MD Anderson Regional Care Center-Katy, Houston, Texas, United States
MD Anderson Regional Care Center-Bay Area, Nassau Bay, Texas, United States
... and 3 other locations.
Dasatinib, Paclitaxel, and Carboplatin in Treating Patients With Stage III-IV or Recurrent Endometrial Cancer
Status: Completed
Last Changed: Apr 05, 2018
First Received: Sep 27, 2011
Disease(s): Endometrial Adenocarcinoma, Endometrial Clear Cell Adenocarcinoma, Endometrial Mucinous Adenocarcinoma, Endometrial Serous Adenocarcinoma, Endometrial Squamous Cell Carcinoma, Endometrial Transitional Cell Carcinoma, Endometrial Undifferentiated Carcinoma, Endometrioid Adenocarcinoma, Recurrent Uterine Corpus Carcinoma, Stage III Uterine Corpus Cancer AJCC v7, Stage IIIA Uterine Corpus Cancer AJCC v7, Stage IIIB Uterine Corpus Cancer AJCC v7, Stage IIIC Uterine Corpus Cancer AJCC v7, Stage IV Uterine Corpus Cancer AJCC v7, Stage IVA Uterine Corpus Cancer AJCC v7, Stage IVB Uterine Corpus Cancer AJCC v7
Intervention(s): Carboplatin, Dasatinib, Laboratory Biomarker Analysis, Paclitaxel
Locations: M D Anderson Cancer Center, Houston, Texas, United States
Improving the Treatment for Women With Early Stage Cancer of the Uterus
Status: Active, not recruiting
Last Changed: Mar 05, 2020
First Received: Sep 17, 2012
Disease(s): Complex Endometrial Hyperplasia With Atypia, Grade 1 Endometrial Endometrioid Adenocarcinoma
Intervention(s): Levonorgestrel, Metformin
Locations: Chris O'Brien Lifehouse, Camperdown, New South Wales, Australia
The Wesley Hospital, Auchenflower, Queensland, Australia
Royal Brisbane and Women's Hospital, Brisbane, Queensland, Australia
Greenslopes Private Hospital, Greenslopes, Queensland, Australia
Mater Health Services, Brisbane, South Brisbane, Queensland, Australia
... and 13 other locations.
Abemaciclib and Letrozole in Treating Patients With Endometrial Cancer
Status: Recruiting
Last Changed: Aug 14, 2019
First Received: Aug 08, 2019
Disease(s): Endometrial Endometrioid Adenocarcinoma
Intervention(s): Abemaciclib, Letrozole, Therapeutic Conventional Surgery
Locations: Northwestern University, Chicago, Illinois, United States
University of Chicago Comprehensive Cancer Center, Chicago, Illinois, United States